Loading chat...

WV SB939

Bill

Status

Engrossed

4/1/2025

Primary Sponsor

Brian Helton

Click for details

Origin

Senate

2025 Regular Session

AI Summary

  • Requires office-based medication-assisted treatment facilities to perform a comprehensive, quantitative, direct observation drug test upon patient admission to a drug program

  • Mandates direct observation, quantitative drug testing every two weeks for the first six weeks after admission

  • Requires direct observation, qualitative or quantitative drug testing every 45 days during the remainder of the first year of treatment

  • After the first year, patients must undergo direct observation drug testing every six months until discharge from the program

  • Providers may request additional direct observation drug tests at any point to assess patient compliance

Legislative Description

Relating to testing for substance use disorder

Health

Last Action

Senate requests House to concur

4/11/2025

Committee Referrals

Health & Human Resources4/2/2025

Full Bill Text

No bill text available